30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

Stryker's Endoscopy Division Acquires Ivy Sports Medicine -

Stryker's Endoscopy division acquired Ivy Sports Medicine, LLC, whose portfolio is comprised of a comprehensive minimally invasive meniscal repair platform. This transaction enables Stryker to offer a complete meniscal platform.

Ivy Sports Medicine's platform includes the only FDA-approved collagen meniscus implant (CMI®) on the market, as stated by the company. CMI is a biocompatible, highly purified collagen scaffold for repair and reinforcement of meniscus defects following partial meniscectomy or for the treatment of irreparable meniscus tears.

The 1st implantation and U.S. launch of CMI was announced in 4Q15.

Source: Stryker, ORTHOWORLD

Stryker is the third largest player in orthopaedics by revenue, accounting for 13% of the total market, and the fourth largest player in the arthroscopy/soft tissue segment, according to ORTHOWORLD estimates. Stay informed on Stryker's activity with their company profile.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.